Important pharmacy news and late-breaking industry information updated daily.

FDA on Friday approved belimumab (Benlysta—GlaxoSmithKline) I.V. infusion for the treatment of children with systemic lupus erythematosus (SLE). Belimumab has been approved for use in adult patients since 2011; however, this is the first time FDA has approved a treatment for pediatric patients with SLE.